Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Deepika Rathna Murugesan
Institution:
Translational Health Science and Technology Institute
Observed institution:
Translational Health Science and Technology Institute
ORCID:
0000-0001-5475-296X
Observed ORCID:
0000-0001-5475-296X
OpenAlex ID:
A5074296733
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months
2022
·
Guruprasad R Medigeshi
, Gaurav Batra
, et al.
·
EBioMedicine
·
51
PDF
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
2024
·
Akshay Binayke
, Aymaan Zaheer
, et al.
·
npj Vaccines
·
30
PDF
Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity
2023
·
Ramachandran Thiruvengadam
, Zaigham Abbas Rizvi
, et al.
·
European journal of medical research
·
25
PDF
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort
2024
·
Ramachandran Thiruvengadam
, Ayushi
, et al.
·
The Lancet Global Health
·
20
Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination
2022
·
Gaurav Batra
, Deepika Rathna Murugesan
, et al.
·
medRxiv
·
1
PDF
When Air Pollutes Life: Examining the Association of PM2.5 on Pregnancy and Fetal Development in North India
2024
·
Sreevatsan Raghavan
, Ekta Chaudhary
, et al.
·
ISEE Conference Abstracts
Show more works
View as search
Works count:
6
Citation count:
127
H-index:
4
I10-index:
4
Year
Topic
Type